1136 / 1816
Chemotherapy – Antracycline based
6 months of anthracycline-based
polychemotherapy (eg, with FAC or
FEC) reduces the annual breast
cancer death rate
• by 38% (SE 5) age <50y
• by 20% (SE 4) age 50–69y
Irrespective of the use of tamoxifen,
oestrogen receptor (ER) status, nodal
status, or other tumour characteristics.
19-9-2017
EBCTCG 2005